Evidence map›Paper›PMID 23238937›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2013

Expression of bile acid receptor TGR5 in gastric adenocarcinoma.

Weibiao Cao, Wei Tian, Jie Hong, Dan Li, Rosemarie Tavares, Lelia Noble, Steven F Moss, Murray B Resnick

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Microbiota of the gastrointestinal tract: Friend or foe?World journal of gastroenterology · 2023
    Review
  9. Article
  10. Bile Acid-Microbiome Interaction Promotes Gastric Carcinogenesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  11. The role of bile acids in carcinogenesis.Cellular and molecular life sciences : CMLS · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Weibiao CaoDepartment of Pathology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. wcao@hotmail.com
Wei Tian
Jie Hong
Dan Li
Rosemarie Tavares
Lelia Noble
Steven F Moss
Murray B Resnick
Rhode Island Hospital · USBrown University · USRenji Hospital · CN

Funding

UCP2 expression in colon cancerP20RR017695 · NCRR · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI RAMRATNAM, BHARAT · 2002 to 2011
$15.0M
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinomaR01DK080703 · NIDDK · RHODE ISLAND HOSPITAL · PI CAO, WEIBIAO · 2009 to 2013
$1.4M
p27 & apoptosis resistance in gastric cancerR01CA111533 · NCI · RHODE ISLAND HOSPITAL · PI MOSS, STEVEN F · 2006 to 2010
$1.2M
NCI NIH HHS R01 CA-111533NCRR NIH HHS P20 RR-17695NIDDK NIH HHS R01 DK-080703NIDDK NIH HHS R01 DK080703
6 · The paper itself

Abstract

Bile reflux is a risk factor in the development of intestinal metaplasia in the stomach and is believed to function as an initiator of gastric carcinogenesis. However, whether the G protein-coupled bile acid receptor TGR5 is expressed in this tumor is not known. In this study, we determined the expression of TGR5 in gastric adenocarcinoma and examined the role of TGR5 in cell proliferation. Strong TGR5 staining was present in 12% of cases of intestinal metaplasia but in no cases of normal gastric epithelium (P < 0.01). Moderate to strong TGR5 membranous and cytoplasmic staining was present in 52% of the intestinal but in only 25% of the diffuse subtype of adenocarcinomas (P < 0.001). Kaplan-Meier univariate survival analysis revealed that moderate to strong TGR5 staining was associated with decreased patient survival (P < 0.05). Treatment with taurodeoxycholic acid (TDCA, a bile acid) significantly increased thymidine incorporation in the AGS gastric adenocarcinoma cell line, suggesting that bile acids may increase cell proliferation. This increase was significantly decreased by knockdown of TGR5 with TGR5 small-interfering RNA (siRNA). In addition, overexpression of TGR5 significantly enhanced TDCA-induced increases in thymidine incorporation. TGR5 is coupled with G(q)α and Gα(i-3) proteins. TDCA-induced increase in thymidine incorporation was significantly decreased by knockdown of G(q)α and Gα(i-3) with their siRNAs. We conclude that TGR5 is overexpressed in most gastric intestinal-type adenocarcinomas, and moderate to strong TGR5 staining is associated with decreased patient survival in all gastric adenocarcinomas. Bile acids increase cell proliferation via activation of TGR5 receptors and G(q)α and Gα(i-3) proteins.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overCell Line, TumorCell ProliferationFemaleGastric MucosaHumansMaleMiddle AgedReceptors, G-Protein-CoupledRNA, MessengerRNA, Small InterferingStomach NeoplasmsSurvival AnalysisGPBAR1 protein, humanReceptors, G-Protein-CoupledRNA, MessengerRNA, Small InterferingTaurodeoxycholic AcidThymidine

Identifiers

PMID23238937
PMCPMC3566614
OpenAlexW2044429737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.